Metformin for neurocognitive dysfunction in schizophrenia: a systematic review

Metformin for neurocognitive dysfunction in schizophrenia: a systematic review

BackgroundThe efficacy and safety of metformin for addressing neurocognitive dysfunction in schizophrenia remain inconclusive. This systematic review evaluates the evidence from randomized controlled trials (RCTs) on the effects of metformin on neurocognitive function in patients with schizophrenia....

Full description

Saved in:
Bibliographic Details
Main Authors: Zhen-Juan Qin, Zhan-Ming Shi, Li-Juan Li, Xin Wei, Hui-Lin Hu, Wei Wei, Zhi-Yuan Xie, Hang-Xi Ji, Yu-Hua Wei, Wei Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Psychiatry
Subjects:
metformin
schizophrenia
neurocognitive dysfunction
systematic review
efficacy
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1540153/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items